Dibenzocyclooctadiene lignans overcome drug resistance in lung cancer cells--study of structure-activity relationship
Language English Country England, Great Britain Media print-electronic
Document type Journal Article, Research Support, Non-U.S. Gov't
PubMed
19531378
DOI
10.1016/j.tiv.2009.06.008
PII: S0887-2333(09)00136-2
Knihovny.cz E-resources
- MeSH
- Cell Division drug effects MeSH
- Drug Resistance, Neoplasm drug effects MeSH
- Cyclooctanes administration & dosage chemistry pharmacology MeSH
- Doxorubicin administration & dosage metabolism pharmacology MeSH
- G2 Phase drug effects MeSH
- Humans MeSH
- Lignans administration & dosage chemistry pharmacology MeSH
- Drug Resistance, Multiple drug effects MeSH
- Cell Line, Tumor MeSH
- Lung Neoplasms drug therapy metabolism MeSH
- Antibiotics, Antineoplastic administration & dosage metabolism pharmacology MeSH
- Carcinoma, Large Cell drug therapy metabolism MeSH
- Dose-Response Relationship, Drug MeSH
- Structure-Activity Relationship MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- Cyclooctanes MeSH
- dibenzocyclooctadiene lignan MeSH Browser
- Doxorubicin MeSH
- Lignans MeSH
- Antibiotics, Antineoplastic MeSH
A panel of nine dibenzo[a,c]cyclooctadiene lignans, schizandrin, gomisin A, gomisin N, gomisin J, angeloylgomisin H, tigloylgomisin P, deoxyschizandrin, gamma-schizandrin and wuweizisu C was examined for their effect on multidrug resistance, as well as their anti-proliferative activities. COR-L23/R, a multidrug resistant sub-line, which has been reported to over-express multidrug resistance-associated protein (MRP1), was used for the experiments together with its parent cell line COR-L23 (human lung cell carcinoma). We found that lignans deoxyschizandrin and gamma-schizandrin at relatively non-toxic concentrations restored the cytotoxic action of doxorubicin to COR-L23/R cells. Deoxyschizandrin and gamma-schizandrin also significantly enhanced the accumulation of doxorubicin in drug resistant cells. Both lignans alone had no effect on the cell cycle; however, when combined with sub-toxic doses of doxorubicin, they induced cell cycle arrest in the G2/M phase, which is typical for toxic doses of doxorubicin. Our results suggest that deoxyschizandrin and gamma-schizandrin potentiate the cytotoxic effect of doxorubicin in doxorubicin resistant lung cancer cells COR-L23/R by increasing the accumulation of doxorubicin inside the cells. The common structural feature of both active lignans is the R-biaryl configuration and the absence of a hydroxy group at C-8. Unlike the reversal effect, the cytotoxicity of lignans with the R-biaryl configuration was similar to that observed for lignans with the S-biaryl configuration.
References provided by Crossref.org
Screening of Natural Compounds as P-Glycoprotein Inhibitors against Multidrug Resistance
Benzimidazoles Downregulate Mdm2 and MdmX and Activate p53 in MdmX Overexpressing Tumor Cells